Development and characterization of transgenic mouse models for conditional gene knockout in the blood-brain and blood-CSF barriers

Transgenic Research

Volumn 21, Issue 1, 2012, Pages 113-130

  Crouthamel, Matthew H ^a,b   Kelly, Edward J ^a   Ho, Rodney J Y ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b University of Washington   (United States)

Author keywords

Blood brain barrier; Blood CSF barrier; Brain; Choroid plexus; Conditional expression; Cre recombinase; Endothelium; Lymphotropic papovavirus; Von Willebrand factor

Indexed keywords

CRE RECOMBINASE; ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN; INTEGRASE; VON WILLEBRAND FACTOR;

ANIMAL; ANTIBODY SPECIFICITY; ARTICLE; BLOOD BRAIN BARRIER; C57BL MOUSE; CEREBROSPINAL FLUID; CHOROID PLEXUS; GENE INACTIVATION; GENETICS; HUMAN; LACTOSE OPERON; METABOLISM; METHODOLOGY; MOUSE; PHYSIOLOGY; PROMOTER REGION; TRANSGENIC MOUSE;

ANIMALS; BLOOD-BRAIN BARRIER; CEREBROSPINAL FLUID; CHOROID PLEXUS; GENE KNOCKOUT TECHNIQUES; GREEN FLUORESCENT PROTEINS; HUMANS; INTEGRASES; LAC OPERON; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; ORGAN SPECIFICITY; PROMOTER REGIONS, GENETIC; VON WILLEBRAND FACTOR;

AFRICAN GREEN MONKEY POLYOMAVIRUS; MUS; MUS MUSCULUS; PAPOVAVIRIDAE;

EID: 84856230669     PISSN: 09628819     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11248-011-9512-z     Document Type: Article

References (41)

1. Aird WC, Jahroudi N, Weiler-Guettler H, Rayburn HB, Rosenberg RD (1995) Human von Willebrand factor gene sequences target expression to a subpopulation of endothelial cells in transgenic mice. Proc Natl Acad Sci USA 92(10): 4567-4571.
2. Alva JA, Zovein AC, Monvoisin A, Murphy T, Salazar A, Harvey NL, Carmeliet P, Iruela-Arispe ML (2006) Ve-cadherin-cre-recombinase transgenic mouse: a tool for lineage analysis and gene deletion in endothelial cells. Dev Dyn 235(3): 759-767.
3. Auerbach AB (2004) Production of functional transgenic mice by DNA pronuclear microinjection. Acta Biochim Pol 51(1): 9-31.
4. Brinster RL, Chen HY, Messing A, van Dyke T, Levine AJ, Palmiter RD (1984) Transgenic mice harboring sv40 t-antigen genes develop characteristic brain tumors. Cell 37(2): 367-379.
5. Brinster RL, Chen HY, Trumbauer ME, Yagle MK, Palmiter RD (1985) Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs. Proc Natl Acad Sci USA 82(13): 4438-4442.
6. Chen JD, van Dyke T (1991) Uniform cell-autonomous tumorigenesis of the choroid plexus by papovavirus large t antigens. Mol Cell Biol 11(12): 5968-5976.
7. Chen JD, Neilson K, van Dyke T (1989) Lymphotropic papovavirus early region is specifically regulated transgenic mice and efficiently induces neoplasia. J Virol 63(5): 2204-2214.
8. de Lange EC (2004) Potential role of abc transporters as a detoxification system at the blood-csf barrier. Adv Drug Deliv Rev 56(12): 1793-1809.
9. Feigenbaum L, Hinrichs SH, Jay G (1992) Jc virus and simian virus 40 enhancers and transforming proteins: role in determining tissue specificity and pathogenicity in transgenic mice. J Virol 66(2): 1176-1182.
10. Geyer J, Gavrilova O, Petzinger E (2009) Brain penetration of ivermectin and selamectin in mdr1a, b p-glycoprotein- and bcrp- deficient knockout mice. J Vet Pharmacol Ther 32(1): 87-96.
11. Gu L, Tsark WM, Brown DA, Blanchard S, Synold TW, Kane SE (2009) A new model for studying tissue-specific mdr1a gene expression in vivo by live imaging. Proc Natl Acad Sci USA 106(13): 5394-5399.
12. Jahroudi N, Lynch DC (1994) Endothelial-cell-specific regulation of von Willebrand factor gene expression. Mol Cell Biol 14(2): 999-1008.
13. Jahroudi N, Schmaier A, Srikanth S, Mahdi F, Lutka FA, Bowser R (2003) VonWillebrand factor promoter targets the expression of amyloid beta protein precursor to brain vascular endothelial cells of transgenic mice. J Alzheimers Dis 5(2): 149-158.
14. Jonker JW, Buitelaar M, Wagenaar E, van Der Valk MA, Scheffer GL, Scheper RJ, Plosch T, Kuipers F, Elferink RP, Rosing H, Beijnen JH, Schinkel AH (2002) The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria. Proc Natl Acad Sci USA 99(24): 15649-15654.
15. Kaddoumi A, Choi SU, Kinman L, Whittington D, Tsai CC, Ho RJ, Anderson BD, Unadkat JD (2007) Inhibition of p-glycoprotein activity at the primate blood-brain barrier increases the distribution of nelfinavir into the brain but not into the cerebrospinal fluid. Drug Metab Dispos 35(9): 1459-1462.
16. Katsuno T, Umeda K, Matsui T, Hata M, Tamura A, Itoh M, Takeuchi K, Fujimori T, Nabeshima Y, Noda T, Tsukita S (2008) Deficiency of zonula occludens-1 causes embryonic lethal phenotype associated with defected yolk sac angiogenesis and apoptosis of embryonic cells. Mol Biol Cell 19(6): 2465-2475.
17. Koni PA, Joshi SK, Temann UA, Olson D, Burkly L, Flavell RA (2001) Conditional vascular cell adhesion molecule 1 deletion in mice: impaired lymphocyte migration to bone marrow. J Exp Med 193(6): 741-754.
18. Kos CH (2004) Cre/loxP system for generating tissue-specific knockout mouse models. Nutr Rev 62(6 Pt 1): 243-246.
19. Kwon GS, Hadjantonakis AK (2009) Transthyretin mouse transgenes direct rfp expression or cre-mediated recombination throughout the visceral endoderm. Genesis 47(7): 447-455.
20. Lakso M, Sauer B, Mosinger B Jr, Lee EJ, Manning RW, Yu SH, Mulder KL, Westphal H (1992) Targeted oncogene activation by site-specific recombination in transgenic mice. Proc Natl Acad Sci USA 89(14): 6232-6236.
21. Lakso M, Pichel JG, Gorman JR, Sauer B, Okamoto Y, Lee E, Alt FW, Westphal H (1996) Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc Natl Acad Sci USA 93(12): 5860-5865.
22. Lorico A, Rappa G, Finch RA, Yang D, Flavell RA, Sartorelli AC (1997) Disruption of the murine mrp (multidrug resistance protein) gene leads to increased sensitivity to etoposide (vp-16) and increased levels of glutathione. Cancer Res 57(23): 5238-5242.
23. Messing A, Pinkert CA, Palmiter RD, Brinster RL (1988) Developmental study of sv40 large t antigen expression in transgenic mice with choroid plexus neoplasia. Oncogene Res 3(1): 87-97.
24. Morita K, Sasaki H, Furuse M, Tsukita S (1999) Endothelial claudin: Claudin-5/tmvcf constitutes tight junction strands in endothelial cells. J Cell Biol 147(1): 185-194.
25. Nagy A (2000) Cre recombinase: the universal reagent for genome tailoring. Genesis 26(2): 99-109.
26. Nagy A, Mar L (2001) Creation and use of a cre recombinase transgenic database. Methods Mol Biol 158: 95-106.
27. Nagy A, Mar L, Watts G (2009) Creation and use of a cre recombinase transgenic database. Methods Mol Biol 530: 365-378.
28. Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N, Furuse M, Tsukita S (2003) Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 161(3): 653-660.
29. Novak A, Guo C, Yang W, Nagy A, Lobe CG (2000) Z/e. g, a double reporter mouse line that expresses enhanced green fluorescent protein upon Cre-mediated excision. Genesis 28(3-4): 147-155.
30. Perraud F, Yoshimura K, Louis B, Dalemans W, Ali-Hadji D, Schultz H, Claudepierre MC, Chartier C, Danel C, Bellocq JP et al (1992) The promoter of the human cystic fibrosis transmembrane conductance regulator gene directing sv40 t antigen expression induces malignant proliferation of ependymal cells in transgenic mice. Oncogene 7(5): 993-997.
31. Rao VV, Dahlheimer JL, Bardgett ME, Snyder AZ, Finch RA, Sartorelli AC, Piwnica-Worms D (1999) Choroid plexus epithelial expression of mdr1 p glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier. Proc Natl Acad Sci USA 96(7): 3900-3905.
32. Salama NN, Kelly EJ, Bui T, Ho RJ (2005) The impact of pharmacologic and genetic knockout of p-glycoprotein on nelfinavir levels in the brain and other tissues in mice. J Pharm Sci 94(6): 1216-1225.
33. Schinkel AH, Smit JJ, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L, Mol CA, van der Valk MA, Robanus-Maandag EC, te Riele HP et al (1994) Disruption of the mouse mdr1a p-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77(4): 491-502.
34. Schinkel AH, Wagenaar E, van Deemter L, Mol CA, Borst P (1995) Absence of the mdr1a p-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin a. J Clin Invest 96(4): 1698-1705.
35. Semprini S, Troup TJ, Kotelevtseva N, King K, Davis JR, Mullins LJ, Chapman KE, Dunbar DR, Mullins JJ (2007) Cryptic loxP sites in mammalian genomes: genome-wide distribution and relevance for the efficiency of bac/pac recombineering techniques. Nucleic Acids Res 35(5): 1402-1410.
36. Sternberg N, Hamilton D (1981) Bacteriophage p1 site-specific recombination. I. Recombination between loxP sites. J Mol Biol 150(4): 467-486.
37. Stratman JL, Barnes WM, Simon TC (2003) Universal pcr genotyping assay that achieves single copy sensitivity with any primer pair. Transgenic Res 12(4): 521-522.
38. Thyagarajan B, Guimaraes MJ, Groth AC, Calos MP (2000) Mammalian genomes contain active recombinase recognition sites. Gene 244(1-2): 47-54.
39. Wijnholds J, deLange EC, Scheffer GL, van den Berg DJ, Mol CA, van der Valk M, Schinkel AH, Scheper RJ, Breimer DD, Borst P (2000) Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier. J Clin Invest 105(3): 279-285.
40. Xu J, Kausalya PJ, Phua DC, Ali SM, Hossain Z, Hunziker W (2008) Early embryonic lethality of mice lacking zo-2, but not zo-3, reveals critical and nonredundant roles for individual zonula occludens proteins in mammalian development. Mol Cell Biol 28(5): 1669-1678.
41. Zhang Y, Huang G, Shornick LP, Roswit WT, Shipley JM, Brody SL, Holtzman MJ (2007) A transgenic FOXJ1-cre system for gene inactivation in ciliated epithelial cells. Am J Respir Cell Mol Biol 36(5): 515-519.